|ZFIN ID: ZDB-PUB-171003-1|
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.
p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis
Li, S.S., Xu, L.Z., Zhou, W., Yao, S., Wang, C.L., Xia, J.L., Wang, H.F., Kamran, M., Xue, X.Y., Dong, L., Wang, J., Ding, X.D., Bella, L., Bugeon, L., Xu, J., Zheng, F.M., Dallman, M.J., Lam, E.W., Liu, Q.
|Source:||Carcinogenesis 38(11): 1092-1103 (Journal)|
|Registered Authors:||Bugeon, Laurence, Dallman, Maggie, Zhou, Wei|
|Keywords:||Breast cancer, metastasis, p62, protein interaction, vimentin|
|PubMed:||28968743 Full text @ Carcinogenesis|
Li, S.S., Xu, L.Z., Zhou, W., Yao, S., Wang, C.L., Xia, J.L., Wang, H.F., Kamran, M., Xue, X.Y., Dong, L., Wang, J., Ding, X.D., Bella, L., Bugeon, L., Xu, J., Zheng, F.M., Dallman, M.J., Lam, E.W., Liu, Q. (2017) p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Carcinogenesis. 38(11):1092-1103.
ABSTRACTThe signalling adaptor p62 is frequently overexpressed in numerous cancer types. Here, we found that p62 expression was elevated in metastatic breast cancer and its overexpression correlated with reduced metastasis-free and relapse-free survival times. Analysis of p62 expression in breast cancer cell lines demonstrated that high p62 expression was associated with the invasive phenotypes of breast cancer. Indeed, silencing p62 expression attenuated the invasive phenotypes of highly metastatic cells, whereas overexpressing p62 promoted the invasion of non-metastatic cells in in vitro microfluidic model. Moreover, MDA-MB-231 cells with p62 depletion which were grown in a three-dimensional culture system exhibited a loss of invasive protrusions. Consistently, genetic ablation of p62 suppressed breast cancer metastasis in both zebrafish embryo and immunodeficient mouse models, as well as decreased tumorigenicity in vivo. To explore the molecular mechanism by which p62 promotes breast cancer invasion, we performed a co-immunoprecipitation (co-IP)-MS analysis and revealed that p62 interacted with vimentin, which mediated the function of p62 in promoting breast cancer invasion. Vimentin protein expression was downregulated upon p62 suppression and upregulated with p62 overexpression in breast cancer cells. Linear regression analysis of clinical breast cancer specimens showed a positive correlation between p62 and vimentin protein expression. Together, our findings provide strong evidence that p62 functions as a tumour metastasis promoter by binding vimentin and promoting its expression. This finding might help to develop novel molecular therapeutic strategies for breast cancer metastasis treatment.